Literature DB >> 2890426

Motor, behavioral and pharmacologic findings in Tourette's syndrome.

J Jankovic1, H Rohaidy.   

Abstract

We studied 112 patients with Tourette's syndrome (TS); the male-to-female ratio was 3.8, the mean age of onset was 7.3 years, and the average duration of symptoms prior to the initial evaluation was 15.2 years. Seventy-nine percent of the patients had at least one family member with motor or vocal tics, and an additional 10 percent had a family member with marked obsessive-compulsive behavior. Simple motor tics occurred as the presenting symptom in about one-third of patients; one-third had multiple motor tics at the onset, and another third started with vocal tics. During the course of the illness all patients developed multifocal motor tics and 86 percent had vocal tics. Verbal and mental coprolalia was present in 44 percent of the patients. Copropraxia was seen in 19 percent of patients, and both coprolalia and copropraxia were more frequent among the males than expected. Attentional deficit disorder was diagnosed in 36 percent of the patients and 32 percent had obsessive-compulsive personality. Sleep disturbances were reported by 62 percent of the patients and polysomnographs in 34 patients showed motor and vocal tics during all stage of sleep, sleep apnea, abnormal arousal pattern, and other sleep disturbances. Patients with mild symptoms improved with clonidine or clonazepam, but those with more advanced disorder required fluphenazine, pimozide, haloperidol or tetrabenazine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890426     DOI: 10.1017/s0317167100038087

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  16 in total

1.  Sleep EEG in Gilles de la Tourette's syndrome.

Authors:  A A Moeller; J C Krieg
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  A controlled study of Tourette syndrome-Revisited: A reply to the letter of Pauls et al.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

3.  A Brazilian cohort of patients with Tourette's syndrome.

Authors:  F Cardoso; C C Veado; J T de Oliveira
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

Review 4.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome.

Authors:  S Cohrs; T Rasch; S Altmeyer; J Kinkelbur; T Kostanecka; A Rothenberger; E Rüther; G Hajak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

Review 6.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

Review 7.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 8.  Tetrabenazine: Spotlight on Drug Review.

Authors:  Navneet Kaur; Puneet Kumar; Sumit Jamwal; Rahul Deshmukh; Vinod Gauttam
Journal:  Ann Neurosci       Date:  2016-09-09

9.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

10.  Tetrabenazine in the treatment of Huntington's disease.

Authors:  Diana Paleacu
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.